Twenty years later: has cell of origin testing in diffuse large B cell lymphoma run its course?

被引：3
|
作者：
Macon, William R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF HEMATOPATHOLOGY | 2020年 / 13卷 / 01期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ELDERLY-PATIENTS; R-CHOP; CHEMOTHERAPY; VINCRISTINE; DOXORUBICIN; CLASSIFICATION; PREDNISONE;
D O I：
10.1007/s12308-020-00390-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [1] Twenty years later: has cell of origin testing in diffuse large B cell lymphoma run its course?
    William R. Macon
    [J]. Journal of Hematopathology, 2020, 13 : 1 - 3
  • [2] Prognostic Significance of Cell of Origin Subclassification in Diffuse Large B Cell Lymphoma
    Dawod, Muath
    Gomez-Gelvez, Juan
    Mattour, Ahmad
    Inamdar, Kedar V.
    Janakiraman, Nalini
    [J]. BLOOD, 2012, 120 (21)
  • [3] Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma - a Single Center Experience
    Brito, Margarida Dantas
    de Castro Campilho, Fernando Manuel
    Ferreira, Rosa Branca
    Vaz, Carlos Pinho
    Roncon, Susana
    Campos, Antonio
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S119 - S120
  • [4] Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome
    Larouche, Jean-Francois
    Berger, Francoise
    Chassagne-Clement, Catherine
    Ffrench, Martine
    Callet-Bauchu, Evelyne
    Sebban, Catherine
    Ghesquieres, Herve
    Broussais-Guillaumot, Florence
    Salles, Gilles
    Coiffier, Bertrand
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2094 - 2100
  • [5] Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma: A Single Portuguese Center Experience
    Dantas Brito, Margarida
    Campilho, Fernando
    Branca, Rosa
    Pinho Vaz, Carlos
    Roncon, Susana
    Campos, Antonio
    [J]. ACTA MEDICA PORTUGUESA, 2016, 29 (03): : 205 - 209
  • [6] Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
    Desai, Sanjal H.
    Mwangi, Raphael
    Smith, Alexandra N.
    Maurer, Matthew J.
    Farooq, Umar
    King, Rebecca L.
    Cerhan, James R.
    Feldman, Andrew L.
    Habermann, Thomas M.
    Thompson, Carrie A.
    Wang, Yucai
    Ansell, Stephen M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (01) : 39 - 49
  • [7] Relapsed Diffuse Large B-Cell Lymphoma: Clinical Utility of Cell of Origin
    Vose, Julie M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4065 - 4066
  • [8] Refining the prognostic impact of the cell of origin in diffuse large B-cell lymphoma
    Balague, O.
    Campo, E.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (05) : 918 - 920
  • [9] Diffuse large B‑cell lymphoma
    David Fuchs
    [J]. memo - Magazine of European Medical Oncology, 2019, 12 : 7 - 11
  • [10] Diffuse large cell lymphoma B
    Alcantara, Marion
    Cottereau, Anne-Segolene
    Garciaz, Sylvain
    Morel, Alexandre
    [J]. HEMATOLOGIE, 2015, 21 : 16 - 22
12345